Medicine and device supply issues
This page provides links to information about current supply issues and our instructions to pharmacists.
Prochlorperazine (Buccastem) (added 27 March 2020)
About stock issues
When PHARMAC is advised that there may be a shortage of a medicine we take measures to ensure that stock is available to New Zealanders.
Many stock shortages do not result in stock running out; deciding when to publicly notify potential impacts to supply is always a judgement call as it may cause an unnecessary run on stock that will result in negative consequences. We work with Medsafe, DHBs, DHB agents, the Pharmacy Guild and other pharmacy-representative groups when deciding what public notice is required and when.
Stock issues and COVID-19
With the outbreak of COVID-19, it’s inevitable that there will be disruptions to supply chains – quarantines may slow or halt activities in manufacturing plants or they may impact transportation and ports. This is a global issue.
We will keep this page up to date as issues arise.
Last updated: 6 April 2020